ClinConnect ClinConnect Logo
Search / Trial NCT01504048

Usefulness of Chromoendoscopy in Diagnosing Microscopic Colitis

Launched by KAROLINSKA UNIVERSITY HOSPITAL · Jan 4, 2012

Trial Information

Current as of April 26, 2025

Unknown status

Keywords

Microscopic Colitis Intestinal Diseases Inflammatory Bowel Diseases

ClinConnect Summary

Microscopic colitis is a common disease found in 10% to 20% of cases having chronic watery diarrhea. Obvious endoscopically identifiable changes of the mucosal surface are usually absent, thus diagnosing microscopic colitis relies on multiple biopsy sampling from all segments of the colon. Chromoendoscopy using indigo-carmine dye spray might, however, unravel mucosal changes in microscopic colitis (Suzuki 2011).

The aim of this study is to investigate if chromoendoscopy using Indigo-Carmine 0.2-0.5% in patients with chronic watery diarrhea is useful in diagnosing microscopic colitis.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with chronic non-bloody diarrhea for at least one month
  • Exclusion Criteria:
  • Patients who decline to participate
  • Unable to give informed consent

About Karolinska University Hospital

Karolinska University Hospital is a leading academic medical center in Sweden, renowned for its commitment to advanced healthcare research and innovative clinical practices. As a key sponsor of clinical trials, the hospital leverages its extensive expertise in medical research and collaboration with Karolinska Institutet, one of the world's foremost medical universities. The institution is dedicated to enhancing patient care through rigorous scientific investigation, focusing on a wide range of therapeutic areas. With a multidisciplinary approach and a strong emphasis on translational medicine, Karolinska University Hospital aims to bridge the gap between laboratory findings and clinical application, ultimately striving to improve health outcomes and advance medical knowledge.

Locations

Stockholm, , Sweden

Patients applied

0 patients applied

Trial Officials

Peter T Schmidt, MD, PhD

Principal Investigator

Karolinska University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials